The presence of nitrosamines in drug products on the market can trigger recalls, causing severe financial and reputational damage. Moreover, during the approval process of a new drug, insufficient data on nitrosamines can lead to costly delays. Download Solvias? white paper for insights into navigating nitrosamine risks and ensuring compliance with regulations.

Company:

View Solvias USA, Inc.'s profile

Links:

https://info.solvias.com/nitrosamine-white-paper